Glenvog 2mg/500mg/0.3mg Tablet SR
Marketer
Astonea Labs Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glenvog 2mg/500mg/0.3mg Tablet SR
Diabetic patients (adults) utilize the anti-diabetic medication, Glenvog 2mg/500mg/0.3mg SR tablets, a combination drug managing type 2 diabetes mellitus. This medication regulates blood glucose; consistent daily dosage, at the same time, maximizes effectiveness. Dosage is determined and potentially adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as cessation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a healthy diet, exercise, and weight management as recommended by your doctor. Commonly, Glenvog 2mg/500mg/0.3mg SR tablets cause hypoglycemia (low blood sugar). Learn to recognize symptoms—sweating, dizziness, headache, trembling—and appropriate countermeasures (fast-acting glucose, like sugary foods or juice). Alcohol consumption increases this risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling (edema), blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) will be determined by your doctor.
Uses of Glenvog 2mg/500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glenvog 2mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Glenvog 2mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume it on an empty stomach.
Common Side effects of Glenvog 2mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glenvog 2mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Glenvog 2mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume it on an empty stomach.
How Glenvog 2mg/500mg/0.3mg Tablet SR works:
Each Glenvog SR tablet (2mg/500mg/0.3mg) contains a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Glenvog 2mg/500mg/0.3mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glenvog 2mg/500mg/0.3mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glenvog 2mg/500mg/0.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glenvog 2mg/500mg/0.3mg SR tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Individuals with liver impairment should use Glenvog 2mg/500mg/0.3mg SR tablets cautiously. Dosage modification of Glenvog 2mg/500mg/0.3mg SR tablets may be necessary. Medical advice is recommended. For patients experiencing mild to moderate liver disease, Glenvog 2mg/500mg/0.3mg SR tablets are typically initiated at a reduced dosage; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glenvog 2mg/500mg/0.3mg Tablet SR :
Should you forget to take a Glenvog 2mg/500mg/0.3mg Tablet SR, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glenvog 2mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently